|Articles|May 8, 2020
UHPLC analysis of challenging MAbs
This application note using YMC-Triart Bio C4 shows a robust separation at high temperatures of 3 commercially available MAbs: Ofatumumab, Palivizumab, and Panitumumab.
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Related Content
Trending on LCGC International
1
Native Capillary Electrophoresis–Mass Spectrometry Enables Quantitative Profiling of Endogenous Protein Complexes
2
Event Preview: 2nd Green Analytical Chemistry Workshop
3
LC–MS Profiling Reveals Diet- and Hypertension-Specific Alterations in Amino Acid Metabolism
4
Best of the Week: Voices From the Analytical Front Line
5